RINALDI, SILVESTRO GIOVANNI
RINALDI, SILVESTRO GIOVANNI
Universita' degli Studi di MILANO
A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck
2017 P. Bossi, R. Miceli, L..D. Locati, D. Ferrari, S. Vecchio, G. Moretti, N. Denaro, F. Caponigro, M. Airoldi, C. Moro, E. Vaccher, A. Sponghini, A. Caldara, S.G. Rinaldi, F. Ferrau, F. Nolè, S. Lo Vullo, F. Tettamanzi, L. Hollander, L.F.L. Licitra
Treatment relevant target immunophenotyping of 139 salivary gland carcinomas (SGCs)
2009 L.D. Locati, F. Perrone, M. Losa, M. Mela, P. Casieri, M. Orsenigo, B. Cortelazzi, T. Negri, E. Tamborini, P. Quattrone, P. Bossi, G. Rinaldi, C. Bergamini, R.G. Calderone, C. Liberatoscioli, L. Licitra
Cetuximab in recurrent and/or metastatic salivary gland carcinomas: A phase II study
2009 L. L. D., B. P., F.P. Perrone, P. P., C. F., M. L., C. P., M.N. Orsenigo, L. M., B. C., C. Liberatoscioli, Q. P., R.G. Calderone, S.G. Rinaldi, P. S., L.F.L. Licitra